AlphaMark Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $4K | Hold |
100
| – | – | ﹤0.01% | 527 |
|
|
2024
Q3 | $6K | Hold |
100
| – | – | ﹤0.01% | 555 |
|
|
2024
Q2 | $6K | Sell |
100
-990
| -91% | -$61.9K | ﹤0.01% | 592 |
|
|
2024
Q1 | $87K | Sell |
1,090
-120
| -10% | -$9.17K | 0.03% | 290 |
|
|
2023
Q4 | $96K | Buy |
1,210
+213
| +21% | +$15.2K | 0.04% | 277 |
|
|
2023
Q3 | $70K | Buy |
997
+112
| +13% | +$7.94K | 0.03% | 293 |
|
|
2023
Q2 | $61K | Sell |
885
-500
| -36% | -$35.6K | 0.03% | 208 |
|
|
2023
Q1 | $103K | Hold |
1,385
| – | – | 0.05% | 157 |
|
|
2022
Q4 | $129K | Hold |
1,385
| – | – | 0.06% | 124 |
|
|
2022
Q3 | $132K | Sell |
1,385
-200
| -13% | -$19.8K | 0.07% | 125 |
|
|
2022
Q2 | $147K | Sell |
1,585
-200
| -11% | -$19.5K | 0.07% | 119 |
|
|
2022
Q1 | $181K | Sell |
1,785
-80
| -4% | -$8.4K | 0.07% | 128 |
|
|
2021
Q4 | $192K | Sell |
1,865
-210
| -10% | -$19.4K | 0.07% | 132 |
|
|
2021
Q3 | $176K | Sell |
2,075
-50
| -2% | -$4.19K | 0.06% | 136 |
|
|
2021
Q2 | $177K | Sell |
2,125
-105
| -5% | -$8.6K | 0.06% | 134 |
|
|
2021
Q1 | $168K | Sell |
2,230
-84
| -4% | -$6.12K | 0.06% | 134 |
|
|
2020
Q4 | $158K | Buy |
2,314
+400
| +21% | +$26K | 0.06% | 129 |
|
|
2020
Q3 | $112K | Buy |
1,914
+50
| +3% | +$3.11K | 0.05% | 141 |
|
|
2020
Q2 | $121K | Buy |
1,864
+672
| +56% | +$42.3K | 0.05% | 126 |
|
|
2020
Q1 | $71K | Buy |
1,192
+51
| +4% | +$3.4K | 0.04% | 151 |
|
|
2019
Q4 | $85K | Buy |
1,141
+252
| +28% | +$17.7K | 0.04% | 165 |
|
|
2019
Q3 | $56K | Buy |
889
+701
| +373% | +$41.5K | 0.02% | 192 |
|
|
2019
Q2 | $10K | Buy |
188
+2
| +1% | +$108 | ﹤0.01% | 332 |
|
|
2019
Q1 | $10K | Sell |
186
-33,758
| -99% | -$2.08M | ﹤0.01% | 317 |
|
|
2018
Q4 | $2.22M | Buy |
33,944
+1,706
| +5% | +$127K | 1.07% | 40 |
|
|
2018
Q3 | $2.54M | Buy |
32,238
+2,095
| +7% | +$150K | 1.02% | 39 |
|
|
2018
Q2 | $1.94M | Buy |
30,143
+30,111
| +94,097% | +$1.98M | 0.79% | 44 |
|
|
2018
Q1 | $2K | Buy |
32
+1
| +3% | +$72 | ﹤0.01% | 471 |
|
|
2017
Q4 | $2K | Hold |
31
| – | – | ﹤0.01% | 470 |
|
|
2017
Q3 | $3K | Hold |
31
| – | – | ﹤0.01% | 449 |
|
|
2017
Q2 | $2K | Hold |
31
| – | – | ﹤0.01% | 483 |
|
|
2017
Q1 | $2K | Buy |
+31
| New | +$2.48K | ﹤0.01% | 459 |
|
Other funds holding CVS
AlphaMark Advisors's CVS Position: Q4 2024 in Review
AlphaMark Advisors held its CVS Health (CVS) position steady in Q4 2024 at 100 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #527.
AlphaMark Advisors first reported a position in CVS in Q1 2017 and has held it in 32 quarters since. The position peaked at $2.54M in Q3 2018. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.
- AlphaMark Advisors held 100 shares of CVS Health worth $4K as of Q4 2024.
- AlphaMark Advisors left its CVS Health share count unchanged in Q4 2024.
- CVS Health made up ﹤0.01% of AlphaMark Advisors's portfolio in Q4 2024, its #527 holding.
- AlphaMark Advisors first reported a position in CVS Health in Q1 2017 and has held it in 32 quarters since.
- AlphaMark Advisors's CVS Health position peaked at $2.54M in Q3 2018.
- 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.
Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.